Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ram Gaud

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
AAPS Pharmscitech|August 29, 2015
Co-Amorphous Combination of Nateglinide-Metformin Hydrochloride for Dissolution EnhancementSarika Wairkar, Ram Gaud
Drug Development and Industrial Pharmacy|October 28, 2008
Formulation and comparative characterization of chitosan, gelatin, and chitosan-gelatin-coated liposomes of CPT-11-HClPravin Shende, Ram Gaud
AAPS Pharmscitech|March 15, 2019
Development and Characterization of Microstructured, Spray-Dried Co-Amorphous Mixture of Antidiabetic Agents Stabilized by SilicateSarika Wairkar, Ram Gaud
Recent Patents on Drug Delivery & Formulation|November 5, 2016
Multi-particulate Systems: Cutting-edge Technology for Controlled Drug DeliverySarika Wairkar, Ram Gaud, Adhithi Raghavan
Therapeutic Delivery|May 23, 2017
A technology roadmap of smart biosensors from conventional glucose monitoring systemsPravin Shende, Pratiksha Sahu, Ram Gaud
The Journal of Pharmacy and Pharmacology|June 8, 2017
Enhanced dissolution and bioavailability of Nateglinide by microenvironmental pH-regulated ternary solid dispersion: in-vitro and in-vivo evaluationSarika Wairkar, Ram Gaud, Namdeo Jadhav
Toxicology Reports|October 1, 2017
<i>In vitro</i> modulatory effects of <i>Terminalia arjuna</i>, arjunic acid, arjunetin and arjungenin on CYP3A4, CYP2D6 and CYP2C9 enzyme activity in human liver microsomesAlice Varghese, Jay Savai, Nancy Pandita, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|September 2, 2018
Pharmacokinetics and pharmacodynamics of intranasally administered selegiline nanoparticles with improved brain delivery in Parkinson's diseaseVinay Sridhar, Ram Gaud, Amrita Bajaj, et al.
International Journal of Biological Macromolecules|December 17, 2017
Pramipexole dihydrochloride loaded chitosan nanoparticles for nose to brain delivery: Development, characterization and in vivo anti-Parkinson activityRuhi Raj, Sarika Wairkar, Vinay Sridhar, et al.
Journal of Drug Targeting|July 7, 2017
Brain targeted delivery of mucoadhesive thermosensitive nasal gel of selegiline hydrochloride for treatment of Parkinson's diseaseVinay Sridhar, Sarika Wairkar, Ram Gaud, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
AAPS Pharmscitech|August 29, 2015
Co-Amorphous Combination of Nateglinide-Metformin Hydrochloride for Dissolution EnhancementSarika Wairkar, Ram Gaud
Drug Development and Industrial Pharmacy|October 28, 2008
Formulation and comparative characterization of chitosan, gelatin, and chitosan-gelatin-coated liposomes of CPT-11-HClPravin Shende, Ram Gaud
AAPS Pharmscitech|March 15, 2019
Development and Characterization of Microstructured, Spray-Dried Co-Amorphous Mixture of Antidiabetic Agents Stabilized by SilicateSarika Wairkar, Ram Gaud
Recent Patents on Drug Delivery & Formulation|November 5, 2016
Multi-particulate Systems: Cutting-edge Technology for Controlled Drug DeliverySarika Wairkar, Ram Gaud, Adhithi Raghavan
Therapeutic Delivery|May 23, 2017
A technology roadmap of smart biosensors from conventional glucose monitoring systemsPravin Shende, Pratiksha Sahu, Ram Gaud
The Journal of Pharmacy and Pharmacology|June 8, 2017
Enhanced dissolution and bioavailability of Nateglinide by microenvironmental pH-regulated ternary solid dispersion: in-vitro and in-vivo evaluationSarika Wairkar, Ram Gaud, Namdeo Jadhav
Toxicology Reports|October 1, 2017
<i>In vitro</i> modulatory effects of <i>Terminalia arjuna</i>, arjunic acid, arjunetin and arjungenin on CYP3A4, CYP2D6 and CYP2C9 enzyme activity in human liver microsomesAlice Varghese, Jay Savai, Nancy Pandita, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|September 2, 2018
Pharmacokinetics and pharmacodynamics of intranasally administered selegiline nanoparticles with improved brain delivery in Parkinson's diseaseVinay Sridhar, Ram Gaud, Amrita Bajaj, et al.
International Journal of Biological Macromolecules|December 17, 2017
Pramipexole dihydrochloride loaded chitosan nanoparticles for nose to brain delivery: Development, characterization and in vivo anti-Parkinson activityRuhi Raj, Sarika Wairkar, Vinay Sridhar, et al.
Journal of Drug Targeting|July 7, 2017
Brain targeted delivery of mucoadhesive thermosensitive nasal gel of selegiline hydrochloride for treatment of Parkinson's diseaseVinay Sridhar, Sarika Wairkar, Ram Gaud, et al.
Pageof 2